TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07201129: A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Sponsor: Viatris Innovation GmbH · Phase: PHASE3 · Area: IMMUNOLOGY · Target Enrollment: 300 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$1,567,680

Rescue Site Savings

+$1,028,790

Unlock Full NCT07201129 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07201129 Rescue Dossier →